டாரோ மருந்து தொழில்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from டாரோ மருந்து தொழில்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In டாரோ மருந்து தொழில்கள் Today - Breaking & Trending Today

Sun Pharma Q1 results: Reports consolidated PAT of Rs 1,444 crore, meets estimates; revenues rise 28%


Sun Pharma Q1 results: Reports consolidated PAT of Rs 1,444 crore, meets estimates; revenues rise 28%
SECTIONS
Sun Pharma Q1 results: Reports consolidated PAT of Rs 1,444 crore, meets estimates; revenues rise 28%ETMarkets.com
Last Updated: Jul 30, 2021, 02:33 PM IST
Share
Synopsis
The company’s consolidated revenues in the quarter rose 28 per cent year-on-year to Rs 9,719 crore, which was sharply above analysts’ expectations.
Agencies
Analysts had expected the company to report consolidated net profit of Rs 1,470 crore for the reported quarter.
MUMBAI:
Sun Pharmaceutical Industries today reported a consolidated net profit of Rs 1,444 crore for the quarter ended June as against a consolidated net loss of Rs 1,655 crore in the year-ago quarter. Analysts had expected the company to report consolidated net profit of Rs 1,470 crore for the reported quarter. ....

Sun Pharma , Dilip Shanghvi , Taro Pharmaceutical Industries , Us Department Of Justice , National Stock Exchange , Managing Director Dilip Shanghvi , National Stock , சூரியன் பார்மா , நீர்த்துப்போக ஷாங்க்வி , டாரோ மருந்து தொழில்கள் , எங்களுக்கு துறை ஆஃப் நீதி , தேசிய ஸ்டாக் பரிமாற்றம் , நிர்வகித்தல் இயக்குனர் நீர்த்துப்போக ஷாங்க்வி , தேசிய ஸ்டாக் ,

Taro: Fiscal Q1 Earnings Snapshot


Taro: Fiscal Q1 Earnings Snapshot
July 27, 2021
FacebookTwitterEmail
HAIFA BAY, Israel (AP) Taro Pharmaceutical Industries Ltd. (TARO) on Tuesday reported a loss of $18.8 million in its fiscal first quarter.
On a per-share basis, the Haifa Bay, Israel-based company said it had a loss of 50 cents. Earnings, adjusted for non-recurring costs, came to $1.09 per share.
The drug maker posted revenue of $147.1 million in the period.
Taro shares have fallen nearly 4% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $70.74, an increase of nearly 9% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TARO at https://www.zacks.com/ap/TARO ....

Taro Pharmaceutical Industries Ltd , Zacks Investment Research , Taro Pharmaceutical Industries , Haifa Bay , Automated Insights , Zacks Investment , டாரோ மருந்து தொழில்கள் லிமிடெட் , ஜாக்கக்ஸ் முதலீடு ஆராய்ச்சி , டாரோ மருந்து தொழில்கள் , ஹைஃபா வளைகுடா , தானியங்கி நுண்ணறிவு , ஜாக்கக்ஸ் முதலீடு ,